Der Maus Monoklonal anti-UBE2C Antikörper (Klon CPTC-UBE2C-1) (ABIN7879294) detektiert spezifisch UBE2C in ELISA und IHC (p).
Dieser Antikörper reagiert spezifisch mit Proben aus Human.
UBE2C
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
1D8
unconjugated
Applikationshinweise
Optimal dilution of the UBE2C antibody should be determined by the researcher.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.2 mg/mL
Buffer
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store the UBE2C antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Target
UBE2C
(Ubiquitin-Conjugating Enzyme E2C (UBE2C))
Andere Bezeichnung
UBE2C
Hintergrund
The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. The first step requires the ATP-dependent activation of the Ub C-terminus and the assembly of multi-Ub chains by the Ub-activating enzyme known as the E1 component. The Ub chain is then conjugated to the Ubconjugating enzyme (E2) to generate an intermediate Ub-E2 complex. The Ub-ligase (E3) then catalyzes the transfer of Ub from E2 to the appropriate protein substrate. UBE2C, also designated UBCH10 in human, is an E2 ubiquitin conjugating enzyme for the anaphase promoting complex (APC), which coordinates mitosis and G1 by sequentially promoting the degradation of key cell-cycle regulators. UBE2C is overexpressed in many different types of cancers and may be a potential therapeutic target.